Anwen Yin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Nlrp Inflammasome

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Lianbo Liu, Qingjie Wang, Yawen Li, Jiali Cai, Yexing Wang, Yun Li, Ru-Xing Wang, Ling Sun, Xiao-Wei Zheng, Anwen Yin
TAT-beclin1 treatment accelerates the development of atherosclerotic lesions in ApoE-deficient mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (13) (2024)
Lianbo Liu, Qingjie Wang, Yawen Li, Jiali Cai, Yexing Wang, Yun Li, Ru-Xing Wang, Ling Sun, Xiao-Wei Zheng, Anwen Yin
TAT-beclin1 treatment accelerates the development of atherosclerotic lesions in ApoE-deficient mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (13) (2024)
Ruosen Yuan, Wei-Feng Zhang, Peng Nie, Keke Lan, Xiaoxiao Yang, Anwen Yin, Qingqing Xiao, Yejiao Shen, Ke Xu, Ben He, Xin Pan, Ling-Hong Shen, Ben He
Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis. Oxidative medicine and cellular longevity 2022 (2022)